Journal article

Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies

Sharon E Johnatty, Amanda B Spurdle, Jonathan Beesley, Xiaoqing Chen, John L Hopper, David L Duffy, Georgia Chenevix-Trench

BREAST CANCER RESEARCH AND TREATMENT | SPRINGER | Published : 2008

Abstract

Association studies aimed at identifying breast cancer susceptibility variants in the progesterone receptor (PGR) gene have been previously reported in the literature with conflicting results, ranging from a protective effect conferred by the PROGINS allele in German Caucasian women, to an increased risk for the leucine variant of the Val660Leu (rs1042838) polymorphism in East Anglian cases. We report the results of genotype and haplotype analyses of five PGR polymorphisms, +44C/T (rs518162), +331G/A (rs10895068), V660L (rs1042838), H770H (rs1042839) and Q886Q (rs500760), conducted on 1,847 Australian breast cancer cases (including 276 cases from a cohort of multiple-case breast cancer famil..

View full abstract